How a Michigan Pharmacist and His Brother Pulled Off a $15 Million Health Care Fraud Scheme
December 1, 2025 | JacobiJournal.com —health care fraud and wire fraud remain pressing concerns in the pharmaceutical industry. In this case, the Kouza brothers orchestrated a sophisticated scheme targeting Medicare, Medicaid, and private insurers, ultimately causing losses exceeding $15 million. Their operations involved submitting false claims for prescription medications that were never dispensed, highlighting systemic weaknesses in pharmacy billing and oversight. The case underscores how health care fraud can exploit gaps in regulatory monitoring and internal pharmacy controls. By falsifying inventory records, overbilling insurers, and concealing shortages from auditors, the perpetrators were able to manipulate the system for nearly a decade. Such schemes not only drain public and private resources but also undermine trust in health care providers and the integrity of reimbursement programs. Federal authorities have increasingly focused on preventing and prosecuting health care fraud, recognizing its widespread financial and legal ramifications. Coordinated efforts by the FBI, HHS-OIG, and DOJ aim to detect anomalies, enforce compliance, and hold perpetrators accountable. For health care providers, the case serves as a reminder to implement robust audits, maintain accurate records, and strengthen internal compliance programs to mitigate exposure to similar fraud schemes. What the Fraud Entailed Federal investigators revealed that from 2010 to 2019, Raad Kouza, 59, and his brother Ramis Kouza, 46, submitted fraudulent claims for prescription medications they never dispensed at their Michigan pharmacies. Key points include: As a result, the scheme cost federal and private insurers more than $15 million, placing a significant financial burden on both government programs and private health plans. Beyond the immediate monetary losses, the fraud disrupted normal claims processing and auditing procedures, forcing insurers to devote additional resources to investigations and corrective actions. The inflated claims also contributed to higher premiums for policyholders, as insurers sought to recoup the losses. Moreover, the case exposed vulnerabilities in pharmacy oversight and regulatory compliance, highlighting the potential for similar schemes to go undetected without rigorous monitoring. The cumulative impact of such health care fraud undermines public trust in the integrity of the health care system and emphasizes the importance of ongoing vigilance and enforcement. Why the Court Issued Prison Sentences In November 2024, a federal jury convicted the brothers of conspiracy to commit health care fraud and wire fraud. At sentencing: Federal prosecutors emphasized that these sentences reflect the severity of deliberate fraud targeting government health programs. How Federal Agencies Investigated the Case The case was investigated by the FBI Detroit Field Office and the HHS Office of Inspector General (OIG). It was prosecuted by the Criminal Division’s Health Care Fraud Strike Force Program, which has charged thousands of defendants nationwide for defrauding federal health programs. The DOJ notes that ongoing oversight by CMS and HHS-OIG aims to prevent similar fraud schemes and hold providers accountable. For readers seeking official details on health care fraud enforcement, visit the DOJ Health Care Fraud Unit. Why This Case Matters Experts say the Kouza case highlights systemic vulnerabilities in pharmacy billing and inventory oversight. It also demonstrates that coordinated federal investigation and prosecution can recover losses and deter future fraudulent activity. Health care providers are encouraged to strengthen internal audits, compliance programs, and reporting mechanisms to reduce exposure to similar legal risks. FAQ: Understanding Health Care Fraud by Pharmacists How do pharmacists commit health care fraud? Fraud can occur through billing for medications not dispensed, overcharging insurers, or falsifying inventory records, as demonstrated in this case. What are the penalties for health care fraud? Convictions can include prison time, restitution, forfeiture, and professional license sanctions, depending on the scale of the scheme. How are pharmacy fraud cases investigated? Federal authorities such as the FBI and HHS-OIG conduct audits, review billing records, and analyze pharmacy operations to detect discrepancies. Can victims recover losses from health care fraud? Yes. Courts often order restitution to recover losses for government programs and insurers impacted by fraudulent schemes. Stay informed on health care fraud and insurance investigations — subscribe to JacobiJournal.com for expert reporting and timely updates. 🔎 Read More from JacobiJournal.com: